logo-loader

Emerald Clinics raises $2.2 million to continue expansion of clinical services

Published: 01:56 28 Aug 2020 EDT

Emerald Clinics Ltd - Emerald Clinics raises $2.2 million as it pursues near-term commercial opportunities
Emerald is planning to change its name to Emyria

Emerald Clinics Ltd (ASX:EMD) has raised $2.2 million via the placement of shares at 8 cents each to fund the expansion of its clinical services, research and development and business development opportunities.

The company’s share placement received strong demand from a combination of new and existing institutional and sophisticated investors in Australia and international markets.

Emerald is focussed on generating real-world evidence using its network of specialist medical clinics and purpose-built, remote patient monitoring software and technology.

The company believes the infusion of new capital will add momentum to its business, buoyed by record monthly sales in July and signing of a major data deal in the UK.

“New capital will add to our momentum”

Emerald CEO Michael Winlo said: “We’re appreciative of the strong response to this capital raising as investors see the recent progress the business has made and its potential.

“Coming off a record month in July and a major data deal in the UK, the injection of new capital will add to our momentum as we pursue various near-term commercial opportunities.”

Name change

Emerald has announced its intention to change its name to Emyria Limited, pending shareholder approval at a general meeting to be held on September 18, 2020.

Coniagas Battery Metals secures new key ground with focus on...

Coniagas Battery Metals (TSX-V:COS) CEO Frank Basa joined Steve Darling from Proactive to announce the company's strategic acquisition of key ground near SOQUEM’s Cardinal Property, located 80 km southeast of Chibougamau, Quebec. This acquisition underscores Coniagas’ commitment to capitalizing...

29 minutes ago